Person Dr Yohan Suryo Rahmanto National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects $relation_to_title = []; $dupes = 0;?> Participant in A Pharmacological Targeting Approach Implementing Albumin as a Carrier of a Novel Chemotherapeutic (funded by National Health and Medical Research Council) Participant in Alpha-2-Macroglobulin and the Transport and Uptake of the Hormone, Hepcidin (funded by National Health and Medical Research Council) Participant in Development of Iron Complexes for the Treatment of FriedreichÍs Ataxia & the Role of Frataxin in Iron Metabolism (funded by National Health and Medical Research Council) Participant in Investigating the Cellular Response to Iron-Depletion: The Trilogy of ASK1, Thioredoxin and Ribonucleotide Reductase (funded by National Health and Medical Research Council) Participant in Melanotransferrin: A “Missing Link” and a Novel Pharmacological Target for Treatment (funded by National Health and Medical Research Council) View all 6 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects $relation_to_title = []; $dupes = 0;?> Participant in A Pharmacological Targeting Approach Implementing Albumin as a Carrier of a Novel Chemotherapeutic (funded by National Health and Medical Research Council) Participant in Alpha-2-Macroglobulin and the Transport and Uptake of the Hormone, Hepcidin (funded by National Health and Medical Research Council) Participant in Development of Iron Complexes for the Treatment of FriedreichÍs Ataxia & the Role of Frataxin in Iron Metabolism (funded by National Health and Medical Research Council) Participant in Investigating the Cellular Response to Iron-Depletion: The Trilogy of ASK1, Thioredoxin and Ribonucleotide Reductase (funded by National Health and Medical Research Council) Participant in Melanotransferrin: A “Missing Link” and a Novel Pharmacological Target for Treatment (funded by National Health and Medical Research Council) View all 6 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover